AnalystsMartin FanMartin Fan's Stock Forecasts
AnalystsMartin Fan
Sectors:
Industries:
Analyst Ranking
Top 23%
#1164 out of 5150 analysts
Average Return
+51.05%
Win Rate
77%10 out of 13
Risk vs Reward
Poor
Good
Martin Fan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +219.03% | $9.46 | $30.18 | 2025-05-15 - 2025-12-12 | Buy |
Aclaris Therapeutics IncACRS | +130.50% | $1.41 | $3.25 | 2025-05-28 - 2025-12-12 | Buy |
Anaptysbio IncANAB | +120.62% | $20.37 | $44.94 | 2025-08-07 - 2025-12-12 | Buy |
Anaptysbio IncANAB | +107.10% | $21.70 | $44.94 | 2025-05-01 - 2025-12-12 | Buy |
Sana Biotechnology IncSANA | +50.73% | $3.41 | $5.14 | 2025-09-24 - 2025-12-12 | Buy |
Martin Fan Analyst Color
Get additional color on Martin Fan's coverage of popular stocks
Martin Fan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vor Biopharma IncVOR | 1 | Hold | $9.00 | -28.06% | Assumes | 18 days ago |
Imagenebio IncIMA | 1 | Sell | $2.00 | -69.23% | Assumes | 18 days ago |
Anaptysbio IncANAB | 4 | Buy | $50.00 | +11.26% | Reiterates | 19 days ago |
Sana Biotechnology IncSANA | 2 | Buy | $6.00 | +16.73% | Maintains | a month ago |
Artiva Biotherapeutics IncARTV | 2 | Buy | $23.00 | +596.97% | Maintains | 2 months ago |
Zenas Biopharma IncZBIO | 1 | Buy | $40.00 | -1.45% | Maintains | 2 months ago |
Cartesian Therapeutics IncRNAC | 1 | Buy | $38.00 | +346.01% | Initiates Coverage On | 5 months ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $8.00 | +146.15% | Initiates Coverage On | 6 months ago |
Oruka Therapeutics IncORKA | 1 | Buy | $40.00 | +32.54% | Reiterates | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.